Cite
HARVARD Citation
Gould, J. et al. (2019). Transvenous lead extraction in patients with cardiac resynchronization therapy devices is not associated with increased 30-day mortality. Europace. 21 (6), pp. 928-936. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Gould, J. et al. (2019). Transvenous lead extraction in patients with cardiac resynchronization therapy devices is not associated with increased 30-day mortality. Europace. 21 (6), pp. 928-936. [Online].